Patent · US Expired

Quinoline derivatives

US6593343B2 · kind B2 · utility

37Cited by

8References

15Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

Anders Bjork · Bjärred, SE
Stig Jonsson · Lund, SE
Tomas Fex · Lund, SE
Gunnar Hedlund · Lund, SE

Key dates

Filing date	Apr 25, 2002
Grant date	Jul 15, 2003
Priority date	—
Expiry date	Apr 25, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) and tautomers thereof are effective for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.